Cytosorbents Market Cap from 2010 to 2024
| CTSO Stock | USD 0.84 0.03 3.70% |
Market Cap | First Reported 2010-12-31 | Previous Quarter 49.6 M | Current Value 47.1 M | Quarterly Volatility 88.1 M |
Check Cytosorbents Crp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cytosorbents main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.1 M, Interest Expense of 150 K or Selling General Administrative of 39.8 M, as well as many exotic indicators such as Price To Sales Ratio of 1.3, Dividend Yield of 0.002 or PTB Ratio of 2.24. Cytosorbents financial statements analysis is a perfect complement when working with Cytosorbents Crp Valuation or Volatility modules.
Cytosorbents | Market Cap |
Latest Cytosorbents Crp's Market Cap Growth Pattern
Below is the plot of the Market Cap of Cytosorbents Crp over the last few years. It is Cytosorbents Crp's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cytosorbents Crp's overall financial position and show how it may be relating to other accounts over time.
| Market Cap | 10 Years Trend |
|
Market Cap |
| Timeline |
Cytosorbents Market Cap Regression Statistics
| Arithmetic Mean | 115,546,640 | |
| Geometric Mean | 83,356,158 | |
| Coefficient Of Variation | 76.25 | |
| Mean Deviation | 71,854,669 | |
| Median | 124,182,724 | |
| Standard Deviation | 88,098,590 | |
| Sample Variance | 7761.4T | |
| Range | 284.7M | |
| R-Value | 0.31 | |
| Mean Square Error | 7567.4T | |
| R-Squared | 0.09 | |
| Significance | 0.26 | |
| Slope | 6,059,952 | |
| Total Sum of Squares | 108659.1T |
Cytosorbents Market Cap History
About Cytosorbents Crp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Cytosorbents Crp income statement, its balance sheet, and the statement of cash flows. Cytosorbents Crp investors use historical funamental indicators, such as Cytosorbents Crp's Market Cap, to determine how well the company is positioned to perform in the future. Although Cytosorbents Crp investors may use each financial statement separately, they are all related. The changes in Cytosorbents Crp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cytosorbents Crp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cytosorbents Crp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cytosorbents Crp. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Market Cap | 49.6 M | 47.1 M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cytosorbents Crp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cytosorbents Crp's short interest history, or implied volatility extrapolated from Cytosorbents Crp options trading.
Pair Trading with Cytosorbents Crp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cytosorbents Crp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cytosorbents Crp will appreciate offsetting losses from the drop in the long position's value.Moving against Cytosorbents Stock
| 0.75 | GCTK | GlucoTrack | PairCorr |
| 0.71 | ELYM | Eliem Therapeutics Trending | PairCorr |
| 0.7 | ELV | Elevance Health Financial Report 17th of July 2024 | PairCorr |
| 0.6 | DXR | Daxor | PairCorr |
| 0.57 | MCK | McKesson Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Cytosorbents Crp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cytosorbents Crp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cytosorbents Crp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cytosorbents Crp to buy it.
The correlation of Cytosorbents Crp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cytosorbents Crp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cytosorbents Crp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cytosorbents Crp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Cytosorbents Crp Correlation against competitors. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for Cytosorbents Stock analysis
When running Cytosorbents Crp's price analysis, check to measure Cytosorbents Crp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cytosorbents Crp is operating at the current time. Most of Cytosorbents Crp's value examination focuses on studying past and present price action to predict the probability of Cytosorbents Crp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cytosorbents Crp's price. Additionally, you may evaluate how the addition of Cytosorbents Crp to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |
Is Cytosorbents Crp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.64) | Revenue Per Share 0.814 | Quarterly Revenue Growth (0.08) | Return On Assets (0.32) | Return On Equity (0.97) |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.